Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Nov 14, 2019 · 10-Q · 45 days after period end · 0001654954-19-013001
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | $2.22M | $1.54M | $1.23M | $4.27M |
| EPS Diluted | -$0.33 | -$1.05 | -$0.87 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 14, 2019 · 45 d after period end
